Zimmer Biomet Holdings has received FDA 510(k) clearance for its OsseoFit Stemless Shoulder System, designed for total shoulder replacement. This advanced implant prioritizes bone preservation while matching the natural anatomy of the humerus for optimal fit and fixation. The system integrates seamlessly with Zimmer Biomet’s Identity Humeral Heads, featuring Versa-Dial Technology for precise offset placement, and the Alliance Glenoid for a wide range of glenoid options tailored to a patient’s anatomy. Equipped with OsseoTi Porous Metal Technology, the implant ensures stable initial fixation and promotes biological integration. Its streamlined design, which includes a single instrument tray, enhances workflow and sterilization efficiency, making it suitable for various surgical settings, including ambulatory centers.
Zimmer Biomet, with over 90 years of leadership in medical innovation, continues to transform patient care through its advanced technologies. The OsseoFit Stemless Shoulder System addresses the growing demand for shoulder replacements among younger, active patients by preserving native bone for potential future revisions. Featuring anatomically shaped implants with press-fit fins and reattachment suture holes for subscapularis repair, the system combines precision and adaptability. Commercial availability is planned for Q1 2025, further solidifying Zimmer Biomet’s commitment to improving mobility and enhancing health outcomes worldwide.
